Cargando…
Age‐stratified reference intervals unlock the clinical potential of circulating cell‐free DNA as a biomarker of poor outcome for healthy individuals and patients with colorectal cancer
Circulating cell‐free DNA (cfDNA) has spurred much interest as a biomarker in oncology. However, inter‐ and intra‐individual cfDNA levels vary greatly. Consequently, in order to base clinical decisions on cfDNA measurements, normal reference intervals are essential to avoid that ordinary variation i...
Autores principales: | Ørntoft, Mai‐Britt Worm, Jensen, Sarah Østrup, Øgaard, Nadia, Henriksen, Tenna Vesterman, Ferm, Linnea, Christensen, Ib Jarle, Reinert, Thomas, Larsen, Ole Halfdan, Nielsen, Hans Jørgen, Andersen, Claus Lindbjerg |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7898909/ https://www.ncbi.nlm.nih.gov/pubmed/33320961 http://dx.doi.org/10.1002/ijc.33434 |
Ejemplares similares
-
Novel DNA methylation biomarkers show high sensitivity and specificity for blood-based detection of colorectal cancer—a clinical biomarker discovery and validation study
por: Jensen, Sarah Østrup, et al.
Publicado: (2019) -
Comparative analysis of 12 different kits for bisulfite conversion of circulating cell-free DNA
por: Worm Ørntoft, Mai-Britt, et al.
Publicado: (2017) -
Circulating tumor DNA for prognosis assessment and postoperative management after curative‐intent resection of colorectal liver metastases
por: Reinert, Thomas, et al.
Publicado: (2022) -
Comparing single‐target and multitarget approaches for postoperative circulating tumour DNA detection in stage II–III colorectal cancer patients
por: Henriksen, Tenna Vesterman, et al.
Publicado: (2022) -
Flow Cytometric Bivariate Analysis of DNA and Cytokeratin in Colorectal Cancer
por: Post, Carolin, et al.
Publicado: (2002)